Genetic variants of parvovirus B19 circulating in Belarus during the epidemic cycle of infection (2005–2016)
https://doi.org/10.29235/1814-6023-2019-16-1-35-45
Abstract
Human parvovirus infection is characterized by a variety of clinical manifestations. Based on the genetic analysis, genotypes 1a, 1b, 2, 3a, 3b of parvovirus B19 are distinguished, which have different geographical distribution. In the period 2005–2016, in Belarus 210 strains of parvovirus B19 isolated from the patients with various forms of parvovirus infection, mainly erythema infectiosum, were genotyped. All strains, except one, belonged to genotype 1a. One strain belonged to genotype 3b and was isolated from a child with aplastic crisis who arrived in Belarus from Kazakhstan for medical care. On the phylogenetic tree, the strains of genotype 1a formed two groups related to the subtypes 1a1 and 1a2. During the 12-year observation, both subtypes circulated in Belarus, but with varying intensity. In the highest incidence years, as well as one or two years before and after this (2005–2008 and 2013–2016), strains of subtype 1a2 predominated in circulation. During the period of low incidence (2009–2012), the dominant position belonged to subtype 1a1. The average genetic distance inside each subtype was 0.51 % for 1a1 and 0.56 % for 1a2. Between subtypes it was also small – 1.32 %. It can be assumed that subtype 1a2 is more new for Belarus and therefore might be connected with the increase of morbidity.
About the Authors
M. A. Yermalovich
Republican Research and Practical Center for Epidemiology and Microbiology
Belarus
Belarus
Marina A. Yermalovich – Ph. D. (Med.), Leading researcher
23, Filimonov Str., 220114, Minsk
G. V. Semeiko
Republican Research and Practical Center for Epidemiology and Microbiology
Belarus
Belarus
Galina V. Semeiko – Ph. D. (Biol.), Leading researcher
23, Filimonov Str., 220114, Minsk
E. O. Samoilovich
Republican Research and Practical Center for Epidemiology and Microbiology
Belarus
Belarus
Elena O. Samoilovich – D. Sc. (Med.), Professor, Head of the Laboratory
23, Filimonov Str., 220114, Minsk
References
1. Qiu J., Söderlund-Venermo M., Young N. S. Human parvoviruses. Clinical Microbiology Reviews, 2017, vol. 30, no. 1, pp. 43–113.
2. Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J. F., Garbarg-Chenon A. Genetic diversity within human erythroviruses: identifcation of three genotypes. Journal of Virology, 2002, vol. 76, no. 18, pp. 9124–9134. https://doi.org/10.1128/jvi.76.18.9124-9134.2002
3. Toan N. L., Duechting A., Kremsner P. G., Song le H., Ebinger M., Aberle S., Binh V. Q., Duy D. N., Torresi J., Kandolf R., Bock C. T. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. Journal of General Virology, 2006, vol. 87, no. 10, pp. 2941–2949. https://doi.org/10.1099/vir.0.82037-0
4. Parsyan A., Szmaragd C., Allain J. P., Candotti D. Identifcation and genetic diversity of two human parvovirus B19 genotype 3 subtypes. Journal of General Virology, 2007, vol. 88, pt. 2, pp. 428–431. https://doi.org/10.1099/vir.0.82496-0
5. Candotti D., Etiz N., Parsyan A., Allain J. P. Identifcation and characterization of persistent human erythrovirus infection in blood donor samples. Journal of Virology, 2004, vol. 78, no. 22, pp. 12169–12178. https://doi.org/10.1128/jvi.78.22.12169-12178.2004
6. Cohen B., Gandhi J., Clewley J. Genetic variants of parvovirus B19 identifed in the United Kingdom: implications for diagnostic testing. Journal of Clinical Virology, 2006, vol. 36, no. 2, pp. 152–155. https://doi.org/10.1016/j.jcv.2006.01.011
7. Hokynar K., Norja P., Laitinen H., Palomäki P., Garbarg-Chenon A., Ranki A,. Hedman K., Söderlund-Venermo M. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. Journal of Clinical Microbiology, 2004, vol. 42, no. 5, pp. 2013–2019. https://doi.org/10.1128/jcm.42.5.2013-2019.2004
8. Hübschen J. M., Mihneva Z., Mentis A. F., Schneider F., Aboudy Y., Grossman Z., Rudich H. [et al.]. Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confrms the predominance of genotype 1 and suggests the spread of genotype 3b. Journal of Clinical Microbiology, 2009, vol. 47, no. 11, pp. 3735–3738. https://doi.org/10.1128/jcm.01201-09
9. Sanabani S., Neto W. K., Pereira J., Sabino E. C. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. Journal of Clinical Microbiology, 2006, vol. 44, no. 2, pp. 604–606. https://doi.org/10.1128/jcm.44.2.604-606.2006
10. Nicolay N., Cotter S. Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996– June 2008. Eurosurveillance, 2009, vol. 14, no. 25, pp. 7–11.
11. Corcoran C., Hardie D., Yeats J., Smuts H. Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identifcation of a novel subtype of genotype 1. Journal of Clinical Microbiology, 2010, vol. 48, no. 1, pp. 137–142. https://doi.org/10.1128/jcm.00610-09
12. Grabarczyk P., Kalińska A., Kara M, Wieczorek R., Ejduk A., Sulkowska E., Gołębiowska-Staroszczyk S., Matysiak M., Baylis S. A., Brojer E. Identifcation and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland. Journal of Medical Virology, 2010, vol. 83, no. 1, pp. 142–149. https://doi.org/10.1002/jmv.21947
13. Lavrent’eva I. N., Antipova A. Yu., Semenov A. V., Bichurina M. A. Genotyping of Parvovirus B19 circulated in Northen-West federal district of Russia. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2013, no. 6, pp. 36–43 (in Russian).
14. Da Costa A. C., Bendit I., de Oliveira A. C. S., Kallas E. G., Sabino E. C., Sanabani S. S. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities. Clinical Microbiology and Infection, 2013, vol. 19, no. 1, E31–E43. https://doi.org/10.1111/1469-0691.12058
15. Rezaei F., Sarshari B., Ghavami N., Meysami P., Shadab A., Salimi H., Mokhtari-Azad T. Prevalence and genotypic characterization of human parvovirus B19 in children with measles- and rubella-like illness in Iran. Journal of Medical Virology, 2015, vol. 88, no. 6, pp. 947–953. https://doi.org/10.1002/jmv.24425
16. De Oliveira M. I., Afonso A. M. S., Curti S. P., Silva P. E., Barbosa T. F., Silva E. R. Junior, Figueiredo C. A. Genotype 1 of human parvovirus B19 in clinical cases. Revista da Associação Médica Brasileira, 2017, vol. 63, no. 3, pp. 224–228. https://doi.org/10.1590/1806-9282.63.03.224
17. Young N. S., Brown K. E. Parvovirus B19. New England Journal of Medicine, 2004, vol. 350, no. 6, pp. 586–597. https://doi.org/10.1056/nejmra030840
18. Ermolovich M. A., Dronina A. M., Samoilovich E. O., Pranovich A. A., Shumanskaya S. Yu. Dynamics of the epidemic process of parvovirus infection in the Republic of Belarus (2005–2016). Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta = Journal of Grodno State Medical University, 2017, vol. 15, no. 4, pp. 414–417 (in Russian).
19. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular Biology and Evolution, 2011, vol. 28, no. 10, pp. 2731–2739. https://doi.org/10.1093/molbev/msr121
20. Yermalovich M. A., Hübschen J. M., Semeiko G. V., Samoilovich E. O., Muller C. P. Human parvovirus B19 surveilance in patients with rash and fever from Belarus. Journal of Medical Virology, 2012, vol. 84, no. 6, pp. 973–978. https://doi.org/10.1002/jmv.23294
21. Umene K., Nunoue T. Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognizing four or fve base pairs and partial nucleotide sequencing: use of sequence variability in virus classifcation. Journal of General Virology, 1991, vol. 72, no. 8, pp. 1997–2001. https://doi.org/10.1099/0022-1317-72-8-1997
22. Freitas R. B., Melo F. L., Oliveira D. S., Romano C. M., Freitas M. R., Macêdo O., Linhares A. C., de A. Zanotto P. M., Durigon E. L. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil. Journal of Clinical Virology, 2008, vol. 43, no. 1, pp. 60–65. https://doi.org/10.1016/j.jcv.2008.03.033
23. Molenaar-de Backer M. W. A., Lukashov V. V., van Binnendijk R. S., Boot H. J., Zaaijer H. L. Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions. PLoS ONE, 2012, vol. 7, no. 8, p. e43206. https://doi.org/10.1371/journal.pone.0043206
24. Cubel Garcia R. C., Pereira R. F., Azevedo K. M., Castro T. X., Mello F. C., Setubal S., Siqueira M. M., Brown D., Oliveira S. A. Molecular diversity of human parvovirus B19 during two outbreaks of erythema infectiosum in Brazil. Brazilian Journal of Infectious Diseases, 2017, vol. 21, no. 1, pp. 102–106. https://doi.org/10.1016/j.bjid.2016.11.002
25. Slavov S. N., Haddad S. K., Silva-Pinto A. C., Amarilla A. A., Alfonso H. L., Aquino V. H., Covas D. T. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors. Journsl of Medical Virology, 2012, vol. 84, no. 10, pp. 1652–1665. https://doi.org/10.1002/jmv.23358
Review
For citations:
Yermalovich M.A., Semeiko G.V., Samoilovich E.O. Genetic variants of parvovirus B19 circulating in Belarus during the epidemic cycle of infection (2005–2016). Proceedings of the National Academy of Sciences of Belarus, Medical series. 2019;16(1):35-45. (In Russ.) https://doi.org/10.29235/1814-6023-2019-16-1-35-45
Views: 620
Email this article 